Achieve Life Sciences, Inc. (ACHV) financial statements and ratios from SEC XBRL: revenue $0.0B (TTM), net margin -3655.4%, revenue growth 668.8% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $1.50M |
| Revenue (TTM) | $0.0B |
| Net Margin | -3655.4% |
| Operating Margin (TTM) | -3655.4% |
| Revenue Growth (YoY) | 668.8% |
| EPS Growth (YoY) | 116.2% |
| Price / Sales | 316.48 |
| FCF Yield | -5.7% |
| Altman Z-Score | 12.95 (safe) |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector P/E (Healthcare) | 21.6 |
ACHV overview · ACHV earnings · ACHV KPIs · ACHV documents · ACHV ownership · ACHV peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.